255 related articles for article (PubMed ID: 18219585)
21. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
22. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
23. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
24. Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda.
Obura B; Alele PE; Obua C
Int J Clin Pharm; 2021 Jun; 43(3):637-644. PubMed ID: 33070297
[TBL] [Abstract][Full Text] [Related]
25. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic medication use in the child and adolescent psychiatry wards of a French hospital.
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Pharm World Sci; 2008 Oct; 30(5):600-4. PubMed ID: 18493863
[TBL] [Abstract][Full Text] [Related]
27. A survey of medicine use in children and adolescents in Austria.
Rauch E; Lagler FB; Herkner H; Gall W; Sauermann R; Hetz S; Male C
Eur J Pediatr; 2018 Oct; 177(10):1479-1487. PubMed ID: 29978258
[TBL] [Abstract][Full Text] [Related]
28. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
29. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
30. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
31. Unlicensed and off-label drug use in a Swiss paediatric university hospital.
Di Paolo ER; Stoetter H; Cotting J; Frey P; Gehri M; Beck-Popovic M; Tolsa JF; Fanconi S; Pannatier A
Swiss Med Wkly; 2006 Apr; 136(13-14):218-22. PubMed ID: 16633971
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for unlicensed and off-label drug use in children outside the hospital.
Schirm E; Tobi H; de Jong-van den Berg LT
Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
[TBL] [Abstract][Full Text] [Related]
33. Paracetamol prescribing in primary care: too little and too much?
Kazouini A; Mohammed BS; Simpson CR; Helms PJ; McLay JS
Br J Clin Pharmacol; 2011 Sep; 72(3):500-4. PubMed ID: 21592184
[TBL] [Abstract][Full Text] [Related]
34. Large differences in neonatal drug use between NICUs are common practice: time for consensus?
Flint RB; van Beek F; Andriessen P; Zimmermann LJ; Liem KD; Reiss IKM; de Groot R; Tibboel D; Burger DM; Simons SHP;
Br J Clin Pharmacol; 2018 Jun; 84(6):1313-1323. PubMed ID: 29624207
[TBL] [Abstract][Full Text] [Related]
35. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
36. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
[TBL] [Abstract][Full Text] [Related]
37. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
38. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
39. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.
Oguz SS; Kanmaz HG; Dilmen U
Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653
[TBL] [Abstract][Full Text] [Related]
40. Identifying Off-Label Prescriptions Through Data Mining in Danish Community Pharmacy Servers: An Exploratory Study on Desmopressin, Diclofenac, Fucidin, Mirtazapine and Quetiapine.
Andrulyte M; Bjerrum OJ
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):155-160. PubMed ID: 29575543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
